For: | Ge L, Wang HJ, Yin D, Lei C, Zhu JF, Cai XH, Zhang GQ. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: A meta-analysis. World J Gastroenterol 2012; 18(48): 7384-7393 [PMID: 23326149 DOI: 10.3748/wjg.v18.i48.7384] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i48/7384.htm |
Number | Citing Articles |
1 |
Christoph Schulz, Frank Kullmann, Volker Kunzmann, Martin Fuchs, Michael Geissler, Ursula Vehling-Kaiser, Heribert Stauder, Axel Wein, Salah-Eddin Al-Batran, Thomas Kubin, Claus Schäfer, Sebastian Stintzing, Clemens Giessen, Dominik Paul Modest, Karsten Ridwelski, Volker Heinemann. NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors. International Journal of Cancer 2015; 137(3): 678 doi: 10.1002/ijc.29403
|
2 |
Bernd-Wolfgang Igl, Inke R. König, Andreas Ziegler. What Do We Mean by ‘Replication’ and ‘Validation’ in Genome-Wide Association Studies?. Human Heredity 2009; 67(1): 66 doi: 10.1159/000164400
|
3 |
Katelin A. Mirkin, Erin K. Greenleaf, Christopher S. Hollenbeak, Joyce Wong. Correlation of clinical and pathological staging and response to neoadjuvant therapy in resected pancreatic cancer. International Journal of Surgery 2018; 52: 221 doi: 10.1016/j.ijsu.2018.01.043
|
4 |
WENJUN CHEN, JIANGUO SHEN, TAO PAN, WENXIAN HU, ZINONG JIANG, XIAOMING YUAN, LINBO WANG. FOLFOX versus EOX as a neoadjuvant chemotherapy regimen for patients with advanced gastric cancer. Experimental and Therapeutic Medicine 2014; 7(2): 461 doi: 10.3892/etm.2013.1449
|
5 |
Kunihiko Izuishi, Mitsuyoshi Kobayashi, Takanori Sano, Hirohito Mori, Kazuo Ebara. Pathological Complete Response and Long-Term Survival in a Very Elderly Patient after Neoadjuvant Chemotherapy for Locally Advanced, Unresectable Gastric Cancer. Case Reports in Oncological Medicine 2014; 2014: 1 doi: 10.1155/2014/532924
|
6 |
Shutaro Gunji, Hiroshi Okabe, Kazutaka Obama, Yoshiharu Sakai. Aortoenteric fistula at the site of esophagojejunostomy after laparoscopic total gastrectomy: report of a case. Surgery Today 2014; 44(11): 2162 doi: 10.1007/s00595-014-0834-3
|
7 |
Ferdinando C. M. Cananzi, Alberto Biondi, Luca Cozzaglio, Domenico D’Ugo, Roberto Persiani, Vittorio Quagliuolo. Preoperative chemotherapy in gastric cancer: expanding the indications, limiting the overuse. Gastric Cancer 2015; 18(1): 200 doi: 10.1007/s10120-014-0359-x
|
8 |
Seow Chee Herng, Norah Htet Htet, Cho Naing, Sandro Pasquali. A comparison of neoadjuvant therapies for gastroesophageal and gastric cancer on tumour resection rate: A network meta-analysis. PLOS ONE 2022; 17(9): e0275186 doi: 10.1371/journal.pone.0275186
|
9 |
Erling A Bringeland, Hans H Wasmuth, Jon E Grønbech. Perioperative chemotherapy for resectable gastric cancer – what is the evidence?. Scandinavian Journal of Gastroenterology 2017; 52(6-7): 647 doi: 10.1080/00365521.2017.1293727
|
10 |
Dimakatso Senthebane, Tina Jonker, Arielle Rowe, Nicholas Thomford, Daniella Munro, Collet Dandara, Ambroise Wonkam, Dhirendra Govender, Bridget Calder, Nelson Soares, Jonathan Blackburn, M. Parker, Kevin Dzobo. The Role of Tumor Microenvironment in Chemoresistance: 3D Extracellular Matrices as Accomplices. International Journal of Molecular Sciences 2018; 19(10): 2861 doi: 10.3390/ijms19102861
|
11 |
Jichun Zhou, Jianguo Shen, Benjamin J. Seifer, Shaojie Jiang, Ji Wang, Hanchu Xiong, Lingmin Xie, Linbo Wang, Xinbing Sui. Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer. Oncotarget 2017; 8(18): 30477 doi: 10.18632/oncotarget.12955
|
12 |
Johanna Mrena, Anne Mattila, Jan Böhm, Ismo Jantunen, Ilmo Kellokumpu. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer. World Journal of Gastroenterology 2015; 21(47): 13294-13301 doi: 10.3748/wjg.v21.i47.13294
|
13 |
S. G. Afanasyev, A. V. Avgustinovich, I. M. Davydov, M. Yu. Volkov. Neoadjuvant chemotherapy in the combined treatment of gastric cancer. Onkologiya. Zhurnal imeni P.A.Gertsena 2014; 3(6): 13 doi: 10.17116/oncolog2014613-18
|
14 |
A. V. Shabunin, D. N. Grekov, I. Yu. Korzheva, Z. A. Bagateliya, V. A. Tsurkan, A. V. Gugnin. The staged treatment of locally advanced stomach cancer complicated by relapsing hemorrhage under conditions of the multi-speciality hospital. Dokazatel'naya gastroenterologiya 2017; 6(4): 78 doi: 10.17116/dokgastro20176478-84
|
15 |
Zhi-Feng Miao, Xing-Yu Liu, Zhen-Ning Wang, Ting-Ting Zhao, Ying-Ying Xu, Yong-Xi Song, Jin-Yu Huang, Hao Xu, Hui-Mian Xu. Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4027-0
|
16 |
A-Man Xu, Lei Huang, Wei Liu, Shuang Gao, Wen-Xiu Han, Zhi-Jian Wei, Tone Frost Bathen. Neoadjuvant Chemotherapy Followed by Surgery versus Surgery Alone for Gastric Carcinoma: Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS ONE 2014; 9(1): e86941 doi: 10.1371/journal.pone.0086941
|
17 |
Mitsugu Kochi, Masashi Fujii, Noriaki Kanamori, Yoshiaki Mihara, Tomoya Funada, Hidenori Tamegai, Megumu Watanabe, Yuriko Takayama, Hiroshi Suda, Tadatoshi Takayama. Phase II Study of Neoadjuvant Chemotherapy With S-1 and CDDP in Patients With Lymph Node Metastatic Stage II or III Gastric Cancer. American Journal of Clinical Oncology 2017; 40(1): 17 doi: 10.1097/COC.0000000000000058
|
18 |
Tongya Wang, Changyang Li, Xiang Li, Jing Zhai, Shoulin Wang, Lizong Shen. The optimal neoadjuvant chemotherapy regimen for locally advanced gastric and gastroesophageal junction adenocarcinoma: a systematic review and Bayesian network meta-analysis. European Journal of Medical Research 2022; 27(1) doi: 10.1186/s40001-022-00878-7
|
19 |
Leila Sisic, Susanne Blank, Henrik Nienhüser, Georg Martin Haag, Dirk Jäger, Tom Bruckner, Katja Ott, Thomas Schmidt, Alexis Ulrich. The postoperative part of perioperative chemotherapy fails to provide a survival benefit in completely resected esophagogastric adenocarcinoma. Surgical Oncology 2020; 33: 177 doi: 10.1016/j.suronc.2017.06.001
|
20 |
Wenli Lin, Zhongxian Huang, Zhenhua Du, Yunshan Wang, Taiyang Zuo. Case Report: Clinical application of continuous arterial infusion chemotherapy in neoadjuvant therapy for locally advanced gastric cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1214599
|
21 |
Paul M. Wilkerson, Stephen T. Hornby, William H. Allum. Adenocarcinoma of the Esophagogastric Junction. 2017; : 139 doi: 10.1007/978-3-319-28776-8_15
|
22 |
Yuki Hirano, Takaaki Konishi, Hidehiro Kaneko, Hidetaka Itoh, Satoru Matsuda, Hirofumi Kawakubo, Kazuaki Uda, Hiroki Matsui, Kiyohide Fushimi, Hiroyuki Daiko, Osamu Itano, Hideo Yasunaga, Yuko Kitagawa. Weight loss during neoadjuvant therapy and short-term outcomes after esophagectomy: a retrospective cohort study. International Journal of Surgery 2023; 109(4): 805 doi: 10.1097/JS9.0000000000000311
|
23 |
Weipeng Gong, Lei Zhao, Zhaogang Dong, Yu Dou, Yanguo Liu, Chao Ma, Xun Qu. After neoadjuvant chemotherapy platelet/lymphocyte ratios negatively correlate with prognosis in gastric cancer patients. Journal of Clinical Laboratory Analysis 2018; 32(5) doi: 10.1002/jcla.22364
|
24 |
Satoshi Tsutsumi, Eiji Oki, Satoshi Ida, Koji Ando, Yasue Kimura, Hiroshi Saeki, Masaru Morita, Tetsuya Kusumoto, Tetsuo Ikeda, Yoshihiko Maehara. Laparoscopic Gastrectomy for Gastric Cancer with Peritoneal Dissemination after Induction Chemotherapy. Case Reports in Gastroenterology 2013; 7(3): 516 doi: 10.1159/000357591
|
25 |
Hansjochen Wilke, Florian Lordick, Hans-Joachim Meyer, Michael Stahl. (Neo)-Adjuvant Chemo(-Radio) Therapy for Adenocarcinomas of the Gastroesophageal Junction and the Stomach in the West. Digestive Surgery 2013; 30(2): 112 doi: 10.1159/000350935
|
26 |
Huang-Wen Tsai, Chih-Chun Chang, Jen-Tang Sun, Ching-Biau Liou, Hsiu-Chen Lin, I-Hsin Lin, Yun-Chieh Yu, Wei-Ling Weng, Ka-I Leong, Tzung-Hai Yen, Jiann-Ming Wu. Clinical Features of Patients with Esophageal and Second Primary Cancers. Asian Pacific Journal of Cancer Prevention 2014; 15(22): 9831 doi: 10.7314/APJCP.2014.15.22.9831
|
27 |
Emmanuel Gabriel, Kristopher Attwood, Sumana Narayanan, Maureen Brady, Steven Nurkin, Steven Hochwald, Moshim Kukar. Does neoadjuvant/perioperative chemotherapy improve overall survival for T2N0 gastric adenocarcinoma?. Journal of Surgical Oncology 2018; 117(4): 659 doi: 10.1002/jso.24894
|
28 |
Ju Seok Kim, Sun Hyung Kang, Hee Seok Moon, Jae Kyu Sung, Hyun Yong Jeong, Ji Young Sul. Clinical Outcome of Doublet and Triplet Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer. The Korean Journal of Gastroenterology 2016; 68(5): 245 doi: 10.4166/kjg.2016.68.5.245
|
29 |
|
30 |
Li-Bo Sun, Guo-Jie Zhao, Da-Yong Ding, Bin Song, Rui-Zhi Hou, Yong-Chao Li. Comparison between better and poorly differentiated locally advanced gastric cancer in preoperative chemotherapy: a retrospective, comparative study at a single tertiary care institute. World Journal of Surgical Oncology 2014; 12(1): 280 doi: 10.1186/1477-7819-12-280
|